Drug repurposing-a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA).

导出 LinkOut

翻译打印收藏纠错

作者： Johanna,McChord ^[1] ; Valeria Martínez,Pereyra ^[1] ; Sarah,Froebel ^[1] ; Raffi,Bekeredjian ^[1] ; Matthias,Schwab ^[2] ; Peter,Ong ^[3]

作者单位： Department of Cardiology and Angiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany. ^[1] Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. ^[2] Departments of Clinical Pharmacology, and Biochemistry and Pharmacy, University Tübingen, Tübingen, Germany. ^[3]

关键词 ANOCA ET-1 receptor blockers drug repurposing refractory angina sGC stimulators

DOI 10.3389/fcvm.2023.1156456

PMID 37396593

发布时间 2023-07-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in cardiovascular medicine

2023年10卷

1156456页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Drug repurposing-a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA).

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Drug repurposing-a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA).

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

检索历史清除